Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution
- PMID: 24126535
- PMCID: PMC4138436
- DOI: 10.1007/s00595-013-0748-5
Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution
Abstract
Purpose: The prognostic differences between right- and left-sided colon cancer are controversial. This study aimed to clarify the clinical difference between right- and left-sided colon cancer.
Methods: We enrolled 820 patients with stage I/II/III colon cancer who underwent radical surgery with curative intent. We explored the impact of the tumor location on the postoperative disease-free survival (DFS) rate using the univariate and multivariate analyses.
Results: Right-sided disease occurred in 399 of the 820 patients. The mean follow-up period was 55.8 ± 34.9 months. The pathological stage distribution was as follows: stage I 261 patients; stage II 283; and stage III 251. There were no significant differences in the five-year DFS of the overall populations (right 88.6%; left 89.4%; P = 0.231). The subgroup analyses demonstrated that patients with stage I right-sided colon cancer had a significantly better 5-year DFS rate than did those with left-sided disease (100 vs. 95.2%, P = 0.034). There were no significant differences in the distributions of the first recurrent sites (P = 0.559).
Conclusions: The tumor location may contribute to postoperative tumor recurrence. However, these effects were inconsistent across tumor stages. Our results provide a better understanding of the prognostic disparity between tumor locations; this may improve patient consent and postoperative surveillance.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4138436/bin/595_2013_748_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4138436/bin/595_2013_748_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4138436/bin/595_2013_748_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4138436/bin/595_2013_748_Fig4_HTML.gif)
Similar articles
-
Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.Chronic Dis Transl Med. 2017 Mar 13;3(1):51-59. doi: 10.1016/j.cdtm.2017.02.004. eCollection 2017 Mar 25. Chronic Dis Transl Med. 2017. PMID: 29063056 Free PMC article.
-
Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.J Gastroenterol. 2020 Oct;55(10):958-968. doi: 10.1007/s00535-020-01706-7. Epub 2020 Jul 10. J Gastroenterol. 2020. PMID: 32651860
-
The impact of tumor location on the biological and oncological differences of colon cancer: Multi-institutional propensity score-matched study.Am J Surg. 2019 Jan;217(1):46-52. doi: 10.1016/j.amjsurg.2018.07.005. Epub 2018 Jul 10. Am J Surg. 2019. PMID: 30384969
-
Right-sided vs. left-sided obstructing colonic cancer: results of a multicenter study of the French Surgical Association in 2325 patients and literature review.Int J Colorectal Dis. 2019 Jun;34(6):1021-1032. doi: 10.1007/s00384-019-03286-2. Epub 2019 Apr 2. Int J Colorectal Dis. 2019. PMID: 30941568 Review.
-
[Right- and left-sided colonic cancer - different tumour entities].Zentralbl Chir. 2010 Aug;135(4):312-7. doi: 10.1055/s-0030-1247471. Epub 2010 Aug 30. Zentralbl Chir. 2010. PMID: 20806133 Review. German.
Cited by
-
Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer.Cells. 2024 Jan 28;13(3):245. doi: 10.3390/cells13030245. Cells. 2024. PMID: 38334637 Free PMC article. Review.
-
Serum Cytokine and miRNA Levels Are Differently Expressed in Right- and Left-Sided Colon Cancer.J Clin Med. 2023 Sep 15;12(18):5986. doi: 10.3390/jcm12185986. J Clin Med. 2023. PMID: 37762927 Free PMC article.
-
Prognostic value of primary tumor location in colorectal cancer: an updated meta-analysis.Clin Exp Med. 2023 Dec;23(8):4369-4383. doi: 10.1007/s10238-023-01120-2. Epub 2023 Jul 5. Clin Exp Med. 2023. PMID: 37405571 Review.
-
Left-Sided Colon Cancer and Right-Sided Colon Cancer: Are They the Same Cancer or Two Different Entities?Cureus. 2023 Apr 14;15(4):e37563. doi: 10.7759/cureus.37563. eCollection 2023 Apr. Cureus. 2023. PMID: 37193477 Free PMC article.
-
Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?Discov Oncol. 2023 Feb 17;14(1):21. doi: 10.1007/s12672-023-00614-5. Discov Oncol. 2023. PMID: 36800051 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources